Wells Fargo’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.1K Buy
10,819
+10,818
+1,081,800% +$99.2K ﹤0.01% 5625
2026
Q1
$5 Hold
1
﹤0.01% 7021
2025
Q4
$3 Hold
1
﹤0.01% 6989
2025
Q3
$1 Hold
1
﹤0.01% 7019
2025
Q2
$1 Hold
1
﹤0.01% 7071
2025
Q1
$1 Hold
1
﹤0.01% 6978
2024
Q4
$1 Hold
1
﹤0.01% 7000
2024
Q3
$1 Hold
1
﹤0.01% 6847
2024
Q2
$1 Sell
1
-85
-99% -$243 ﹤0.01% 6809
2024
Q1
$357 Buy
86
+2
+2% +$7 ﹤0.01% 6362
2023
Q4
$271 Buy
84
+4
+5% +$9 ﹤0.01% 6523
2023
Q3
$239 Buy
80
+1
+1% +$3 ﹤0.01% 6541
2023
Q2
$90 Buy
79
+4
+5% +$6 ﹤0.01% 6895
2023
Q1
$126 Hold
75
﹤0.01% 6885
2022
Q4
$93 Buy
75
+2
+3% +$5 ﹤0.01% 6811
2022
Q3
$0 Sell
73
-8
-10% -$32 ﹤0.01% 6629
2022
Q2
$0 Buy
81
+6
+8% +$26 ﹤0.01% 6769
2022
Q1
$0 Sell
75
-12
-14% -$61 ﹤0.01% 7016
2021
Q4
$0 Buy
87
+26
+43% +$109 ﹤0.01% 7189
2021
Q3
$0 Buy
61
+12
+24% +$46 ﹤0.01% 6941
2021
Q2
$0 Hold
49
﹤0.01% 6880
2021
Q1
$0 Buy
49
+7
+17% +$34 ﹤0.01% 6867
2020
Q4
$0 Hold
42
﹤0.01% 6466
2020
Q3
$0 Buy
42
+13
+45% +$46 ﹤0.01% 6309
2020
Q2
$0 Buy
29
+7
+32% +$24 ﹤0.01% 6264
2020
Q1
$0 Buy
+22
New +$76 ﹤0.01% 6172
2016
Q1
Hold
0
6179
2015
Q4
Hold
0
6203
2015
Q3
Hold
0
6180

Other funds holding ARMP

Wells Fargo's ARMP Position: Q2 2026 in Review

Wells Fargo increased its Armata Pharmaceuticals (ARMP) stake by 1,081,800% in Q2 2026, buying an estimated $99.2K and bringing the position to 10,819 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5625.

Wells Fargo first reported a position in ARMP in Q1 2020 and has held it in 26 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Wells Fargo held 10,819 shares of Armata Pharmaceuticals worth $70.1K as of Q2 2026.
  • Wells Fargo bought 10,818 Armata Pharmaceuticals shares in Q2 2026, an estimated $99.2K.
  • Armata Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5625 holding.
  • Wells Fargo first reported a position in Armata Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.